Dietary manipulation ketogenic diet for Metabolic Regulation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metabolic Regulation+2 More
Dietary manipulation ketogenic diet - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how changes in diet affect a recently discovered metabolic regulator's blood levels in healthy adults. The hypothesis is that key regulatory factors involved in lipid oxidation will respond to changes in diet, especially fasting and diet-induced ketosis.

Eligible Conditions
  • Metabolic Regulation
  • Ketogenic Dieting
  • Fasting

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Metabolic Regulation

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 week

1 week
A is change in energy expenditure with diet-induced ketosis.
Changes in circulating plasma levels of key metabolic regulators

Trial Safety

Safety Progress

1 of 3

Other trials for Metabolic Regulation

Trial Design

3 Treatment Groups

12 day ketogenic diet
1 of 3
3 day ketogenic diet
1 of 3
16 hour fast
1 of 3
Experimental Treatment

20 Total Participants · 3 Treatment Groups

Primary Treatment: Dietary manipulation ketogenic diet · No Placebo Group · N/A

12 day ketogenic diet
Behavioral
Experimental Group · 1 Intervention: Dietary Manipulation - 12 day ketogenic diet · Intervention Types: Behavioral
3 day ketogenic diet
Behavioral
Experimental Group · 1 Intervention: Dietary manipulation ketogenic diet · Intervention Types: Behavioral
16 hour fast
Behavioral
Experimental Group · 1 Intervention: 16 Hour Fast · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 week

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
772 Previous Clinical Trials
848,533 Total Patients Enrolled
Eleftheria Maratos Flier, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center

Eligibility Criteria

Age 18 - 65 · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: October 8th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.